GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery
GemPharmatech's antibody discovery platform aims to accelerate development of next-generation cancer therapies GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. https://mma.prnewswire.com/media/2667644/GemPharmatech__Logo.jpg Through the non-exclusive agreement, researchers at Memorial Sloan Kettering will have […]